| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 144.557 | 162.377 | 187.868 | 205.192 | 200.532 | 222.633 | 219.534 | 142.720 | 108.295 | 114.502 |
| Total Income - EUR | 144.585 | 162.540 | 188.114 | 205.400 | 200.833 | 222.634 | 219.535 | 142.764 | 108.300 | 114.502 |
| Total Expenses - EUR | 143.751 | 164.924 | 184.366 | 194.008 | 194.585 | 206.613 | 203.200 | 139.669 | 116.617 | 114.108 |
| Gross Profit/Loss - EUR | 834 | -2.385 | 3.748 | 11.392 | 6.248 | 16.021 | 16.335 | 3.094 | -8.317 | 394 |
| Net Profit/Loss - EUR | 429 | -2.385 | 1.878 | 9.329 | 4.230 | 14.039 | 14.578 | 1.663 | -8.317 | 394 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Depoferm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 20.443 | 12.930 | 8.007 | 4.426 | 1.096 | 86 | 1.318 | 2.927 | 2.434 | 4.095 |
| Current Assets | 53.465 | 52.294 | 64.507 | 78.180 | 90.464 | 73.906 | 74.054 | 56.217 | 42.446 | 35.759 |
| Inventories | 34.326 | 35.445 | 50.968 | 48.965 | 51.415 | 58.170 | 53.390 | 46.943 | 36.362 | 24.159 |
| Receivables | 14.875 | 7.786 | 9.304 | 6.776 | 4.320 | 2.740 | 6.497 | 249 | 3.135 | 7.624 |
| Cash | 4.264 | 9.063 | 4.236 | 22.438 | 34.729 | 12.996 | 14.167 | 9.025 | 2.949 | 3.976 |
| Shareholders Funds | 17.329 | 14.768 | 16.395 | 25.423 | 29.161 | 48.224 | 54.252 | 5.388 | -2.945 | -2.534 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 56.579 | 50.456 | 58.006 | 59.035 | 62.400 | 25.768 | 21.121 | 58.703 | 47.826 | 42.694 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4613 - 4613" | |||||||||
| CAEN Financial Year |
4613
|
|||||||||
Comments - Depoferm Srl